Olopatadine Hydrochloride, >98.0%(HPLC)(T), 250mg

3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline, 95.0%, 1g

4-{[butyl(methyl)amino]sulfonyl}benzoic acid, 95.0%, 250mg

D-(+)-Camphoric acid, 95.0%, 100g

2,4,6-Tribromo-3-methylphenol, 5g

1-Methyl-1H-indazol-4-amine, 95.0%, 250mg

(2S,5R)-Ethyl 5-((benzyloxy)amino)piperidine-2-carboxylate, 98%, 100mg

2'-Hydroxy-4',6'-dimethoxy-2-(4-methoxyphenyl)acetophenone>98.0%(GC)1g

Ethyl 3-hydroxybutanoate, 95.0%, 25g

Lanthan(III)-oxid, 99,99 %, p.a., 100 g, kunststoffverpackung.

1-(1-METHYLNAPHTHALEN-4-YL)ETHANONE, 95.0%, 10g

2-((4-Ethoxyphenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 10g

Chloressigsäureethylester, >=98 %, zur Synthese, 250 ml, Glasverpackung